|
[1]
|
Cai, S.C., Allen, J.C., Lim, Y.L., et al. (2014) Mortality of Bullous Pemphigoid in Singapore: Risk Factors and Causes of Death in 359 Patients Seen at the National Skin Centre. British Journal of Dermatology, 170, 1319-1326. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Li, J., Zuo, Y.G. and Zheng, H.Y. (2013) Mortality of Bullous Pemphigoid in China. JAMA Dermatology, 149, 106-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
中国医师协会皮肤科医师分会自身免疫性疾病亚专业委员会. 大疱性类天疱疮诊断和治疗的专家建议[J]. 中华皮肤科杂志, 2016, 49(6): 384-387.
|
|
[4]
|
赵晓东, 吕传柱, 于学忠, 等. 急诊成人细菌性感染诊疗专家共识[J]. 中国急救医学, 2020, 40(11): 1029-1035.
|
|
[5]
|
Persson, M.S.M., Harman, K.E., Vinogradova, Y., et al. (2021) Incidence, Prevalence and Mortality of Bullous Pemphigoid in England 1998-2017: A Population-Based Cohort Study. British Journal of Dermatology, 184, 68-77. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Langan, S.M., Smeeth, L., Hubbard, R., et al. (2008) Bullous Pemphigoid and Pemphigus Vulgaris—Incidence and Mortality in the UK: Population Based Cohort Study. BMJ, 337, a180. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Joly, P., Baricault, S., Sparsa, A., et al. (2012) Incidence and Mortality of Bullous Pemphigoid in France. The Journal of Investigative Dermatology, 132, 1998-2004. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Försti, A.K., Jokelainen, J., Timonen, M., et al. (2014) Increasing Incidence of Bullous Pemphigoid in Northern Finland: A Retrospective Database Study in Oulu University Hospital. British Journal of Dermatology, 171, 1223-1226. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Brick, K.E., Weaver, C.H., Lohse, C.M., et al. (2014) Incidence of Bullous Pemphigoid and Mortality of Patients with Bullous Pemphigoid in Olmsted County, Minnesota, 1960 through 2009. Journal of the American Academy of Dermatology, 71, 92-99. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kridin, K. and Ludwig, R.J. (2018) The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations. Frontiers in Medicine, 5, Article No. 220. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Chen, J., Mao, X., Zhao, W., et al. (2020) Assessment of the Characteristics and Associated Factors of Infectious Complications in Bullous Pemphigoid. Frontiers in Immunology, 11, Article No. 1607. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Hsu, D.Y., Brieva, J., Sinha, A.A., et al. (2016) Comorbidities and Inpatient Mortality for Pemphigus in the U.S.A. British Journal of Dermatology, 174, 1290-1298. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Leshem, Y.A., Gdalevich, M., Ziv, M., et al. (2014) Opportunistic Infections in Patients with Pemphigus. Journal of the American Academy of Dermatology, 71, 284-292. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Shiohara, J., Yoshida, K., Hasegawa, J., et al. (2010) Tetracycline and Niacinamide Control Bullous Pemphigoid but not Pemphigus Foliaceus When These Conditions Coexist. The Journal of Dermatology, 37, 657-661. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Hornschuh, B., Hamm, H., Wever, S., et al. (1997) Treatment of 16 Patients with Bullous Pemphigoid with Oral Tetracycline and Niacinamide and Topical Clobetasol. Journal of the American Academy of Dermatology, 36, 101-103. [Google Scholar] [CrossRef]
|
|
[16]
|
Noel, A.R., Attwood, M., Bowker, K.E., et al. (2021) The Pharmacodynamics of Minocycline Alone and in Combination with Rifampicin against Staphylococcus Aureus Studied in an in Vitro Pharmacokinetic Model of Infection. Journal of Antimicrobial Chemotherapy, 76, 1840-1844. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Ren, Z., Narla, S., Hsu, D.Y., et al. (2018) Association of Serious Infections with Pemphigus and Pemphigoid: Analysis of the Nationwide Inpatient Sample. Journal of the European Academy of Dermatology and Venereology, 32, 1768-1776. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
姚香君, 张琪, 王婷, 等. 656例自身免疫性大疱病住院患者皮肤感染的危险因素及病原学分析[J]. 中国麻风皮肤病杂志, 2021, 37(8): 494-498.
|